In response to recent technological breakthroughs and a doubling of research and development funding by Octillion Corp, the Company is pleased to announce that, in addition to recently added managerial and support staff, it has increased its research staff to four, with plans to further boost research personnel, contingent upon ongoing results from the development of the Company's first-of-its-kind transparent glass window capable of generating electricity.
Applied Nanoscience, Inc. today announced that it will coordinate all of the necessary remaining tests to have Emergency Filtration Products, Inc., its proposed merger partner, file a new 510(k) notification for the NanoMask with the Food and Drug Administration (FDA).
ThalesNano Inc. announced today that it has launched the latest of its Cube flow reactor series, H-Cube Midi. This novel product is now commercially available and validated with several important chemistry applications.
Chemical Computing Group Inc. (CCG) and Molecular Networks GmbH today announce the integration of CORINA, Molecular Networks' premium three-dimensional molecular model-generating program into CCG's comprehensive and powerful life science modeling suite Molecular Operating Environment (MOE).
BIND Biosciences, Inc., a privately held biopharmaceutical company focused on developing therapeutic targeted nanoparticles, announced today that it has been awarded a six month $150,000 Phase I SBIR contract from the National Cancer Institute to develop a targeted therapy for hormone refractory prostate cancer.
The European Nanotechnology Trade Alliance (ENTA) is holding a one day meeting on December 5, 2007, for companies to input into the development of a Nanotechnology Code of Conduct for European Industry.
AmberWave Systems, a leader in the research, development and licensing of advanced technologies for semiconductor manufacturing, announces an in-licensing agreement with the University of California, Santa Barbara to collaborate on, and fund, materials science research within the field of mesoporous materials.
Arrowhead Research Corporation announced today that its majority-owned subsidiary, Aonex Technologies, Inc. and partner Sandia National Laboratories have successfully demonstrated the growth of high-quality gallium nitride on Aonex's proprietary A-GaN substrates.